pharma · Adolescent Patients (13 to 17 years of age) with Schizophrenia · Adolescent patient (13-17 years of age) with Schizophrenia
Gedeon Richter
Gedeon Richter Plc.
Gedeon Richter patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Budapest, EU
- Employees
- 2,763
- Programs
- 2
- Drugs
- 5
- Patents
- 0
Gedeon Richter patents
0 pharmaceutical patents indexed for Gedeon Richter. 0 expire within 24 months.
Gedeon Richter has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Gedeon Richter have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Gedeon Richter patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.